Tag:
SL052
Latest Headlines
Latest Headlines
Quest doses first prostate cancer patient with photodynamic therapy
Quest PharmaTech has treated the first patient in the company's Phase I clinical trial of its SL052 photodynamic therapy for prostate cancer. The study will evaluate the localization, safety,
